EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 930K -10.58% | 1.68M 80.65% | 5.64M 235.71% | 10.736M 90.35% | 14.892M 38.71% | 26.546M 78.26% | |
| EBITDA YoY % growth | -28.63M -29.66% | -27.74M 3.11% | -23.912M 13.80% | -17.034M 28.76% | -17.862M -4.86% | -12.576M 29.59% | |
| EBIT YoY % growth | -30.86M -24.39% | -30.32M 1.75% | -26.524M 12.52% | -23.574M 11.12% | -22.86M 3.03% | -18.518M 19.00% | |
| Operating Margin | -3,318.28% | -1,804.76% | -470.28% | -219.58% | -153.51% | -69.76% | |
| EPS YoY % growth | -6.90 17.50% | -6.40 7.25% | -5.30 17.19% | -4.20 20.81% | -3.17 24.42% | -2.24 29.26% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.75 41.94% | -0.74 6.93% | -0.90 15.32% | -0.81 38.49% | -0.63 16.22% |
| Revenue Q2Q % growth | 3.698M 539.79% | 4.08M -2.63% | 1.53M 67.40% | 2.55M 41.98% | 5.1M 37.91% |
| EBITDA Q2Q % growth | -3.857M 23.10% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.03M 34.06% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.31 -63.75% | -1.03 | -0.28 | -27.16% |
| Q2 2024 Q2Q % growth | -1.06 37.65% | -1.28 | 0.21 | 16.86% |
| Q1 2024 Q2Q % growth | -0.80 46.67% | -0.97 | 0.17 | 17.44% |
| Q4 2023 Q2Q % growth | -1.30 -85.71% | -1.43 | 0.13 | 8.96% |
| Q3 2023 Q2Q % growth | -0.80 50.00% | -1.60 | 0.80 | 49.94% |
| Q2 2023 Q2Q % growth | -1.70 19.05% | -1.79 | 0.09 | 4.76% |
| Q1 2023 Q2Q % growth | -1.50 25.00% | -1.63 | 0.13 | 8.09% |
| Q4 2022 Q2Q % growth | -0.70 61.11% | -2.04 | 1.34 | 65.69% |
| Q3 2022 Q2Q % growth | -1.60 15.79% | -2.04 | 0.44 | 21.57% |
| Q2 2022 Q2Q % growth | -2.10 -40.00% | -1.84 | -0.26 | -14.38% |
| Q1 2022 Q2Q % growth | -2.00 -17.65% | -1.79 | -0.21 | -12.04% |
| Q4 2021 Q2Q % growth | -1.80 28.00% | -2.09 | 0.29 | 13.92% |
| Q3 2021 Q2Q % growth | -1.90 | -1.73 | -0.17 | -9.57% |
| Q2 2021 Q2Q % growth | -1.50 | -1.84 | 0.34 | 18.30% |
| Q1 2021 Q2Q % growth | -1.70 | -1.84 | 0.14 | 7.41% |
| Q4 2020 Q2Q % growth | -2.50 | -1.73 | -0.77 | -44.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.796M -52.32% | 2.907M | -1.111M | -38.22% |
| Q2 2024 Q2Q % growth | 914K 39.76% | 816K | 98K | 12.01% |
| Q1 2024 Q2Q % growth | 4.19M 553.67% | 3.57M | 620K | 17.37% |
| Q4 2023 Q2Q % growth | 578K -12.42% | 510K | 68K | 13.33% |
| Q3 2023 Q2Q % growth | 3.767M 701.49% | 1.204M | 2.563M | 212.87% |
| Q2 2023 Q2Q % growth | 654K 110.97% | 902.7K | -248.7K | -27.55% |
| Q1 2023 Q2Q % growth | 641K 167.08% | 887.4K | -246.4K | -27.77% |
| Q4 2022 Q2Q % growth | 660K 112.90% | 433.5K | 226.5K | 52.25% |
| Q3 2022 Q2Q % growth | 470K 213.33% | 102K | 368K | 360.78% |
| Q2 2022 Q2Q % growth | 310K 121.43% | 102K | 208K | 203.92% |
| Q1 2022 Q2Q % growth | 240K -27.27% | 306K | -66K | -21.57% |
| Q4 2021 Q2Q % growth | 310K -11.43% | 204K | 106K | 51.96% |
| Q3 2021 Q2Q % growth | 150K -53.13% | 275.4K | -125.4K | -45.53% |
| Q2 2021 Q2Q % growth | 140K -53.33% | 306K | -166K | -54.25% |
| Q1 2021 Q2Q % growth | 330K 312.50% | 306K | 24K | 7.84% |
| Q4 2020 Q2Q % growth | 350K 191.67% | 350K | % | |
| Q3 2020 Q2Q % growth | 320K 220.00% | % | ||
| Q2 2020 Q2Q % growth | 300K 57.89% | % | ||
| Q1 2020 Q2Q % growth | 80K -77.14% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -543.48% | -12.89% | -12.89% |
| Revenue | 0% | 20.85% | -17.46% | -30.3% |